{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:17:48Z","timestamp":1786465068971,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-026-00852-6","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:45:07Z","timestamp":1780573507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lower respiratory microbiota as modulators of tumor immunity in lung adenocarcinoma"],"prefix":"10.1186","volume":"27","author":[{"given":"Yingchun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minliang","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"852_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"852_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12957-025-03701-9","volume":"23","author":"S Xin","year":"2025","unstructured":"Xin S, Wen M, Tian Y, Dong H, Wan Z, Jiang S, et al. Impact of histopathological subtypes on invasive lung adenocarcinoma: from epidemiology to tumour microenvironment to therapeutic strategies. World J Surg Oncol. 2025;23:66. https:\/\/doi.org\/10.1186\/s12957-025-03701-9.","journal-title":"World J Surg Oncol"},{"key":"852_CR3","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1097\/CM9.0000000000003442","volume":"137","author":"Y Wu","year":"2024","unstructured":"Wu Y, He S, Cao M, Teng Y, Li Q, Tan N, et al. Comparative analysis of cancer statistics in China and the United States in 2024. Chin Med J (Engl). 2024;137:3093\u2013100. https:\/\/doi.org\/10.1097\/CM9.0000000000003442.","journal-title":"Chin Med J (Engl)"},{"key":"852_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev-physiol-021115-105238","volume":"78","author":"RP Dickson","year":"2016","unstructured":"Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB. The Microbiome and the Respiratory Tract. Annu Rev Physiol. 2016;78:481\u2013504. https:\/\/doi.org\/10.1146\/annurev-physiol-021115-105238.","journal-title":"Annu Rev Physiol"},{"key":"852_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40168-016-0151-8","volume":"4","author":"BJ Kelly","year":"2016","unstructured":"Kelly BJ, Imai I, Bittinger K, Laughlin A, Fuchs BD, Bushman FD, et al. Composition and dynamics of the respiratory tract microbiome in intubated patients. Microbiome. 2016;4:7. https:\/\/doi.org\/10.1186\/s40168-016-0151-8.","journal-title":"Microbiome"},{"key":"852_CR6","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal Microbiota Promote Lung Cancer Development via \u03b3\u03b4 T Cells. Cell. 2019;176:998\u2013e101316. https:\/\/doi.org\/10.1016\/j.cell.2018.12.040.","journal-title":"Cell"},{"key":"852_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/ijc.31098","volume":"142","author":"H Liu","year":"2018","unstructured":"Liu H, Tao L, Zhang J, Zhu Y, Zheng Y, Liu D, et al. Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects. Int J Cancer. 2018;142:769\u201378. https:\/\/doi.org\/10.1002\/ijc.31098.","journal-title":"Int J Cancer"},{"key":"852_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41392-023-01722-y","volume":"9","author":"R Li","year":"2024","unstructured":"Li R, Li J, Zhou X. Lung microbiome: new insights into the pathogenesis of respiratory diseases. Signal Transduct Target Ther. 2024;9:19. https:\/\/doi.org\/10.1038\/s41392-023-01722-y.","journal-title":"Signal Transduct Target Ther"},{"key":"852_CR9","first-page":"8","volume":"17","author":"KS Akinosoglou","year":"2013","unstructured":"Akinosoglou KS, Karkoulias K, Marangos M. Infectious complications in patients with lung cancer. Eur Rev Med Pharmacol Sci. 2013;17:8\u201318.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"852_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/futurepharmacol5030034","volume":"5","author":"SM Sohag","year":"2025","unstructured":"Sohag SM, Toma SN, Imon MdA-I, Maihemuti M, Ahmed F, Mimi MA, et al. Tumor Microenvironment: An Emerging Landscape for Lung Cancer Therapy. Future Pharmacol. 2025;5:34. https:\/\/doi.org\/10.3390\/futurepharmacol5030034.","journal-title":"Future Pharmacol"},{"key":"852_CR11","doi-asserted-by":"publisher","first-page":"108333","DOI":"10.1016\/j.pharmthera.2022.108333","volume":"241","author":"J Peng","year":"2023","unstructured":"Peng J, Yang S, Ng CSH, Chen GG. The role of FOXP3 in non-small cell lung cancer and its therapeutic potentials. Pharmacol Ther. 2023;241:108333. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108333.","journal-title":"Pharmacol Ther"},{"key":"852_CR12","doi-asserted-by":"publisher","first-page":"684098","DOI":"10.3389\/fonc.2021.684098","volume":"11","author":"DR Principe","year":"2021","unstructured":"Principe DR, Chiec L, Mohindra NA, Munshi HG. Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer. Front Oncol. 2021;11:684098. https:\/\/doi.org\/10.3389\/fonc.2021.684098.","journal-title":"Front Oncol"},{"key":"852_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-80962-1_25-1","volume-title":"Handbook of Cancer and Immunology","author":"S Tahmasebi","year":"2023","unstructured":"Tahmasebi S, Alimohammadi M, Khorasani S, Rezaei N. Pro-tumorigenic and Anti-tumorigenic Roles of Pro-inflammatory Cytokines in Cancer. In: Rezaei N, editor. Handbook of Cancer and Immunology. Cham: Springer International Publishing; 2023. pp. 1\u201325. https:\/\/doi.org\/10.1007\/978-3-030-80962-1_25-1."},{"key":"852_CR14","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.21037\/tlcr-24-393","volume":"13","author":"P Liang","year":"2024","unstructured":"Liang P, Chen Q, Chen X, Zhang X, Xiao Y, Liang G, et al. Microbiota modulate immune repertories in lung adenocarcinoma via microbiota-immunity interactive network. Transl Lung Cancer Res. 2024;13:2683\u201397. https:\/\/doi.org\/10.21037\/tlcr-24-393.","journal-title":"Transl Lung Cancer Res"},{"key":"852_CR15","doi-asserted-by":"publisher","first-page":"679829","DOI":"10.3389\/fimmu.2021.679829","volume":"12","author":"Q Dong","year":"2021","unstructured":"Dong Q, Chen ES, Zhao C, Jin C. Host-Microbiome Interaction in Lung Cancer. Front Immunol. 2021;12:679829. https:\/\/doi.org\/10.3389\/fimmu.2021.679829.","journal-title":"Front Immunol"},{"key":"852_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev-physiol-021115-105238","volume":"78","author":"RP Dickson","year":"2016","unstructured":"Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB. The Microbiome and the Respiratory Tract. Annu Rev Physiol. 2016;78:481\u2013504. https:\/\/doi.org\/10.1146\/annurev-physiol-021115-105238 . Epub 2015 Nov 2. PMID: 26527186; PMCID: PMC4751994.","journal-title":"Annu Rev Physiol"},{"key":"852_CR17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12931-021-01919-1","volume":"22","author":"HJ Jang","year":"2021","unstructured":"Jang HJ, Choi JY, Kim K, Yong SH, Kim YW, Kim SY, et al. Relationship of the lung microbiome with PD-L1 expression and immunotherapy response in lung cancer. Respir Res. 2021;22:322. https:\/\/doi.org\/10.1186\/s12931-021-01919-1.","journal-title":"Respir Res"},{"key":"852_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ejca.2023.01.024","volume":"183","author":"M Hilmi","year":"2023","unstructured":"Hilmi M, Kamal M, Vacher S, Dupain C, Ibadioune S, Halladjian M, et al. Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial. Eur J Cancer. 2023;183:152\u201361. https:\/\/doi.org\/10.1016\/j.ejca.2023.01.024.","journal-title":"Eur J Cancer"},{"key":"852_CR19","doi-asserted-by":"publisher","first-page":"1606551","DOI":"10.3389\/frmbi.2025.1606551","volume":"4","author":"A Bailey","year":"2025","unstructured":"Bailey A, Leuther KK, Robinson LA. The microbiome and lung cancer: microbial effects on host immune responses and treatment outcomes. Front Microbiomes. 2025;4:1606551. https:\/\/doi.org\/10.3389\/frmbi.2025.1606551.","journal-title":"Front Microbiomes"},{"key":"852_CR20","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.3390\/cancers14194813","volume":"14","author":"M Bou Zerdan","year":"2022","unstructured":"Bou Zerdan M, Kassab J, Meouchy P, Haroun E, Nehme R, Bou Zerdan M, et al. The Lung Microbiota and Lung Cancer: A Growing Relationship. Cancers. 2022;14:4813. https:\/\/doi.org\/10.3390\/cancers14194813.","journal-title":"Cancers"},{"key":"852_CR21","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1016\/j.celrep.2018.08.090","volume":"24","author":"V Le Noci","year":"2018","unstructured":"Le Noci V, Guglielmetti S, Arioli S, Camisaschi C, Bianchi F, Sommariva M, et al. Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases. Cell Rep. 2018;24:3528\u201338. https:\/\/doi.org\/10.1016\/j.celrep.2018.08.090.","journal-title":"Cell Rep"},{"key":"852_CR22","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/biom15111525","volume":"15","author":"KA Papavassiliou","year":"2025","unstructured":"Papavassiliou KA, Sofianidi AA, Spiliopoulos FG, Margoni A, Papavassiliou AG. Emerging Issues Regarding the Effects of the Microbiome on Lung Cancer Immunotherapy. Biomolecules. 2025;15:1525. https:\/\/doi.org\/10.3390\/biom15111525.","journal-title":"Biomolecules"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00852-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00852-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00852-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T14:03:31Z","timestamp":1786457011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12865-026-00852-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["852"],"URL":"https:\/\/doi.org\/10.1186\/s12865-026-00852-6","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board (IRB) of The Second Affiliated Hospital of Yichun University (Approval no. 2025.019). The requirement for informed consent to participate was waived by the ethics committee due to the retrospective nature of the study.Patient consent was waived due to the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"75"}}